Literature DB >> 20952539

CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1.

Bartlomiej Bartkowiak1, Pengda Liu, Hemali P Phatnani, Nicholas J Fuda, Jeffrey J Cooper, David H Price, Karen Adelman, John T Lis, Arno L Greenleaf.   

Abstract

Drosophila contains one (dCDK12) and humans contain two (hCDK12 and hCDK13) proteins that are the closest evolutionary relatives of yeast Ctk1, the catalytic subunit of the major elongation-phase C-terminal repeat domain (CTD) kinase in Saccharomyces cerevisiae, CTDK-I. However, until now, neither CDK12 nor CDK13 has been demonstrated to be a bona fide CTD kinase. Using Drosophila, we demonstrate that dCDK12 (CG7597) is a transcription-associated CTD kinase, the ortholog of yCtk1. Fluorescence microscopy reveals that the distribution of dCDK12 on formaldehyde-fixed polytene chromosomes is virtually identical to that of hyperphosphorylated RNA polymerase II (RNAPII), but is distinct from that of P-TEFb (dCDK9 + dCyclin T). Chromatin immunoprecipitation (ChIP) experiments confirm that dCDK12 is present on the transcribed regions of active Drosophila genes. Compared with P-TEFb, dCDK12 amounts are lower at the 5' end and higher in the middle and at the 3' end of genes (both normalized to RNAPII). Appropriately, Drosophila dCDK12 purified from nuclear extracts manifests CTD kinase activity in vitro. Intriguingly, we find that cyclin K is associated with purified dCDK12, implicating it as the cyclin subunit of this CTD kinase. Most importantly, we demonstrate that RNAi knockdown of dCDK12 in S2 cells alters the phosphorylation state of the CTD, reducing its Ser2 phosphorylation levels. Similarly, in human HeLa cells, we show that hCDK13 purified from nuclear extracts displays CTD kinase activity in vitro, as anticipated. Also, we find that chimeric (yeast/human) versions of Ctk1 containing the kinase homology domains of hCDK12/13 (or hCDK9) are functional in yeast cells (and also in vitro); using this system, we show that a bur1(ts) mutant is rescued more efficiently by a hCDK9 chimera than by a hCDK13 chimera, suggesting the following orthology relationships: Bur1 ↔ CDK9 and Ctk1CDK12/13. Finally, we show that siRNA knockdown of hCDK12 in HeLa cells results in alterations in the CTD phosphorylation state. Our findings demonstrate that metazoan CDK12 and CDK13 are CTD kinases, and that CDK12 is orthologous to yeast Ctk1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952539      PMCID: PMC2956209          DOI: 10.1101/gad.1968210

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain.

Authors:  E J Cho; M S Kobor; M Kim; J Greenblatt; S Buratowski
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

2.  RNA-binding protein Nrd1 directs poly(A)-independent 3'-end formation of RNA polymerase II transcripts.

Authors:  E J Steinmetz; N K Conrad; D A Brow; J L Corden
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

Review 3.  Indirect immunofluorescent labeling of Drosophila polytene chromosomes: visualizing protein interactions with chromatin in vivo.

Authors:  Brian E Schwartz; Janis K Werner; John T Lis
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

4.  Fractionation of transcription factors for RNA polymerase II from Drosophila Kc cell nuclear extracts.

Authors:  D H Price; A E Sluder; A L Greenleaf
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

5.  The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro.

Authors:  W A Zehring; J M Lee; J R Weeks; R S Jokerst; A L Greenleaf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation.

Authors:  Kelby O Kizer; Hemali P Phatnani; Yoichiro Shibata; Hana Hall; Arno L Greenleaf; Brian D Strahl
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Transcription factor and polymerase recruitment, modification, and movement on dhsp70 in vivo in the minutes following heat shock.

Authors:  Amber K Boehm; Abbie Saunders; Janis Werner; John T Lis
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats.

Authors:  Janice C Jones; Hemali P Phatnani; Timothy A Haystead; Justin A MacDonald; S Munir Alam; Arno L Greenleaf
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

9.  CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles.

Authors:  T K Ko; E Kelly; J Pines
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

10.  Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.

Authors:  Zhenhua Guo; John W Stiller
Journal:  BMC Genomics       Date:  2004-09-20       Impact factor: 3.969

View more
  191 in total

Review 1.  RNA polymerase II elongation control.

Authors:  Qiang Zhou; Tiandao Li; David H Price
Journal:  Annu Rev Biochem       Date:  2012-03-09       Impact factor: 23.643

2.  Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B.

Authors:  Zuyao Ni; Jonathan B Olsen; Xinghua Guo; Guoqing Zhong; Eric Dongliang Ruan; Edyta Marcon; Peter Young; Hongbo Guo; Joyce Li; Jason Moffat; Andrew Emili; Jack F Greenblatt
Journal:  Transcription       Date:  2011 Sep-Oct

3.  The cyclin K/Cdk12 complex: an emerging new player in the maintenance of genome stability.

Authors:  Dalibor Blazek
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

4.  The transcription elongation factor Bur1-Bur2 interacts with replication protein A and maintains genome stability during replication stress.

Authors:  Emanuel Clausing; Andreas Mayer; Sittinan Chanarat; Barbara Müller; Susanne M Germann; Patrick Cramer; Michael Lisby; Katja Strässer
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

5.  CSB-Dependent Cyclin-Dependent Kinase 9 Degradation and RNA Polymerase II Phosphorylation during Transcription-Coupled Repair.

Authors:  Lise-Marie Donnio; Anna Lagarou; Gabrielle Sueur; Pierre-Olivier Mari; Giuseppina Giglia-Mari
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

Review 6.  Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy.

Authors:  Jiaoti Huang; Jason K Wang; Yin Sun
Journal:  Curr Opin Urol       Date:  2013-05       Impact factor: 2.309

7.  Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins.

Authors:  Ibraheem Ali; Diego Garrido Ruiz; Zuyao Ni; Jeffrey R Johnson; Heng Zhang; Pao-Chen Li; Mir M Khalid; Ryan J Conrad; Xinghua Guo; Jinrong Min; Jack Greenblatt; Matthew Jacobson; Nevan J Krogan; Melanie Ott
Journal:  Mol Cell       Date:  2019-05-01       Impact factor: 17.970

8.  Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.

Authors:  Poorval M Joshi; Shari L Sutor; Catherine J Huntoon; Larry M Karnitz
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

9.  Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

Authors:  Tinghu Zhang; Nicholas Kwiatkowski; Calla M Olson; Sarah E Dixon-Clarke; Brian J Abraham; Ann K Greifenberg; Scott B Ficarro; Jonathan M Elkins; Yanke Liang; Nancy M Hannett; Theresa Manz; Mingfeng Hao; Bartlomiej Bartkowiak; Arno L Greenleaf; Jarrod A Marto; Matthias Geyer; Alex N Bullock; Richard A Young; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2016-08-29       Impact factor: 15.040

10.  CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Authors:  Gang Yang; Yicheng Wang; Jianchun Xiao; Fangyu Zhao; Jiangdong Qiu; Yueze Liu; Guangyu Chen; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cell Oncol (Dordr)       Date:  2020-10-30       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.